Literature DB >> 25501349

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.

C Chabannon1, M Hildebrandt2, S Scheding3, A Humpe4, M Lowdell5, I Slaper-Cortenbach6.   

Abstract

Mesh：

Year:  2014        PMID： 25501349     DOI： 10.1038/bmt.2014.271

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.

Authors:  Lynne M Ball; Maria E Bernardo; Helene Roelofs; Maarten J D van Tol; Benedetta Contoli; Jaap Jan Zwaginga; Maria Antonia Avanzini; Antonella Conforti; Alice Bertaina; Giovanna Giorgiani; Cornelia M Jol-van der Zijde; Marco Zecca; Katarina Le Blanc; Francesco Frassoni; Rudolph Maarten Egeler; Willem E Fibbe; Arjan C Lankester; Franco Locatelli
Journal:  Br J Haematol       Date:  2013-08-31       Impact factor: 6.998

2.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

Authors:  P Ljungman; M Bregni; M Brune; J Cornelissen; T de Witte; G Dini; H Einsele; H B Gaspar; A Gratwohl; J Passweg; C Peters; V Rocha; R Saccardi; H Schouten; A Sureda; A Tichelli; A Velardi; D Niederwieser
Journal:  Bone Marrow Transplant       Date:  2009-07-06       Impact factor: 5.483

3.  Hematopoietic-cell transplantation at 50.

Authors:  Frederick R Appelbaum
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

4.  Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

Authors:  Tobias Feuchtinger; Kathrin Opherk; Wolfgang A Bethge; Max S Topp; Friedhelm R Schuster; Eva M Weissinger; Mohamad Mohty; Reuven Or; Michael Maschan; Michael Schumm; Klaus Hamprecht; Rupert Handgretinger; Peter Lang; Hermann Einsele
Journal:  Blood       Date:  2010-07-12       Impact factor: 22.113

5.  Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors:  Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

6.  Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.

Authors:  Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

7.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

8.  Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

Authors:  M de Lima; J McMannis; A Gee; K Komanduri; D Couriel; B S Andersson; C Hosing; I Khouri; R Jones; R Champlin; S Karandish; T Sadeghi; T Peled; F Grynspan; Y Daniely; A Nagler; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2008-01-21       Impact factor: 5.483

9.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

10.  Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.

Authors:  Alois Gratwohl; Ronald Brand; Dietger Niederwieser; Helen Baldomero; Christian Chabannon; Jan Cornelissen; Theo de Witte; Per Ljungman; Fiona McDonald; Eoin McGrath; Jakob Passweg; Christina Peters; Vanderson Rocha; Ineke Slaper-Cortenbach; Anna Sureda; Andre Tichelli; Jane Apperley
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544
View more
  2 in total

1.  Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.

Authors:  Jakob R Passweg; Helen Baldomero; Christian Chabannon; Selim Corbacioglu; Rafael de la Cámara; Harry Dolstra; Bertram Glass; Raffaella Greco; Mohamad Mohty; Bénédicte Neven; Régis Peffault de Latour; Zinaida Perić; John A Snowden; Ibrahim Yakoub-Agha; Anna Sureda; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2022-02-22       Impact factor: 5.174

2.  Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.

Authors:  Jakob R Passweg; Helen Baldomero; Christian Chabannon; Grzegorz W Basak; Rafael de la Cámara; Selim Corbacioglu; Harry Dolstra; Rafael Duarte; Bertram Glass; Raffaella Greco; Arjan C Lankester; Mohamad Mohty; Régis Peffault de Latour; John A Snowden; Ibrahim Yakoub-Agha; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2021-02-23       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.